ArticleScientific reports2025

Synergistic activity of tafasitamab and metronomic chemotherapy on diffuse large B-cell lymphoma through inhibition of the AKT/mTOR signaling pathway.

Marta Banchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.